Cytokine induced metalloproteinase expression and activity does not correlate with focal susceptibility of articular cartilage to degeneration.
Abstract: To determine whether the focal susceptibility to cartilage degeneration in joints is related to a differential response to cytokine stimulation. Methods: Compare aggrecan and collagen catabolism in in-vitro models of cartilage degradation induced by retinoic acid (RA), interleukin-1 (IL-1), tumor necrosis factor alpha (TNF) and IL-1 plus oncostatin M (OSM). Glycosaminoglycan (GAG) and hydroxyproline (HyPro) quantification and Western immunoblot analyses of aggrecan and collagen degradation products were undertaken in explant cultures of normal cartilage from regions of equine joints with a known high and low susceptibility to degeneration in disease. RNA isolation and semi quantitative reverse transcription-polymerase chain reaction (RT-PCR) analysis were performed to determine the expression of aggrecanases, matrix metalloproteinases (MMPs) and their inhibitors. Results: Although the rate of basal cartilage aggrecan turnover was dependent on joint region there was no difference in the response of different cartilages to cytokines. Individual animals did show a significant difference in the response of certain cartilages to cytokines, with both decreased and increased aggrecan loss in cartilage with a low susceptibility to degeneration. Aggrecan release in both short- and long-term cultures from all cartilages was associated with increased cleavage by aggrecanases rather than MMPs. There was a poor correlation between expression of aggrecanases, MMPs or their inhibitors and cytokine induced aggrecan catabolism. IL-1 alone was able to stimulate collagen breakdown in equine articular cartilage and surprisingly, significantly more collagen loss was induced in cartilage from regions less susceptible to degeneration. Conclusions: Collectively, these studies suggest that a regional difference in response to catabolic cytokines is unlikely to be a factor in the initiation of focal cartilage degeneration in osteoarthritis (OA).
Publication Date: 2005-02-08 PubMed ID: 15694578DOI: 10.1016/j.joca.2004.10.014Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Journal Article
Summary
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
The study investigates the role of certain proteins in the degeneration of cartilage commonly seen in osteoarthritis, and concludes that regional susceptibility to cartilage damage doesn’t appear to be influenced by these proteins’ response to inflammation-causing substances.
Objective and Methodology of the Study
- This study was undertaken to ascertain if the varying susceptibility to cartilage degradation in different areas of a joint is linked to their distinctive reaction to cytokine stimulation. Cytokines are small proteins vital in cellular signaling, which can trigger inflammation.
- The analysis involved comparison of the breakdown of aggrecan and collagen, two major components of cartilage, in lab models of cartilage degradation induced by several substances including retinoic acid, interleukin-1, and tumor necrosis factor alpha, and the combination of interleukin-1 and oncostatin M.
- By monitoring glycosaminoglycan and hydroxyproline quantities and conducting protein analyses of collagen and aggrecan degradation products, researchers studied explant cultures of normal cartilage from areas of horse joints known for high and low susceptibility to degeneration during disease conditions.
- In addition, an investigation was carried out regarding the expression of aggrecanases and matrix metalloproteinases, which are enzymes that break down cartilage, and their inhibitors, using techniques such as RNA isolation and semi-quantitative reverse transcription-polymerase chain reaction analysis.
Key Findings of the Study
- There was no significant difference identified in the way different cartilages responded to cytokines, even though the rate of basic cartilage aggrecan turnover depended on the joint region.
- While individual animals did exhibit a significant difference in the reaction of certain cartilages to cytokines, the observed alternations involved both decreased and increased loss of aggrecan in cartilage that had a lower susceptibility to degradation.
- The study found that the release of aggrecan was associated with heightened cleavage by aggrecanases rather than matrix metalloproteinases.
- Interestingly, it was discovered that interleukin-1 alone was capable of inciting collagen breakdown in equine articular cartilage. Furthermore, more collagen loss was instigated in cartilage sourced from regions less susceptible to degeneration.
- The research thus unveiled a weak correlation between the expression of aggrecanases, matrix metalloproteinases, their inhibitors and cytokine-induced aggrecan degradation.
Conclusion
- Based on the data collected, the study concludes that a regional difference in response to catabolic cytokines is unlikely to be a contributory factor in the initiation of localized cartilage degeneration commonly seen in osteoarthritis.
Cite This Article
APA
Little CB, Flannery CR, Hughes CE, Goodship A, Caterson B.
(2005).
Cytokine induced metalloproteinase expression and activity does not correlate with focal susceptibility of articular cartilage to degeneration.
Osteoarthritis Cartilage, 13(2), 162-170.
https://doi.org/10.1016/j.joca.2004.10.014 Publication
Researcher Affiliations
- Raymond Purves Bone and Joint Research Laboratories, University of Sydney at the Royal North Shore Hospital, St. Leonards 2065, NSW, Australia. cblittle@med.usyd.edu.au
MeSH Terms
- Aggrecans
- Animals
- Cartilage, Articular / drug effects
- Cartilage, Articular / physiopathology
- Collagen / metabolism
- Culture Media, Serum-Free
- Cytokines / pharmacology
- Extracellular Matrix Proteins / metabolism
- Forelimb
- Glycosaminoglycans / analysis
- Growth Inhibitors / pharmacology
- Horses
- Hydroxyproline / analysis
- Interleukin-1 / pharmacology
- Keratolytic Agents / pharmacology
- Lectins, C-Type
- Matrix Metalloproteinases / metabolism
- Metalloproteases / analysis
- Metalloproteases / metabolism
- Oncostatin M
- Peptides / pharmacology
- Proteoglycans / metabolism
- RNA, Messenger / analysis
- Reverse Transcriptase Polymerase Chain Reaction / methods
- Tissue Culture Techniques
- Tretinoin / pharmacology
- Tumor Necrosis Factor-alpha / pharmacology
Citations
This article has been cited 13 times.- Pagani S, Maglio M, Sicuro L, Fini M, Giavaresi G, Brogini S. RNA Extraction from Cartilage: Issues, Methods, Tips.. Int J Mol Sci 2023 Jan 20;24(3).
- Dechêne L, Colin M, Demazy C, Fransolet M, Niesten A, Arnould T, Serteyn D, Dieu M, Renard P. Characterization of the Proteins Secreted by Equine Muscle-Derived Mesenchymal Stem Cells Exposed to Cartilage Explants in Osteoarthritis Model.. Stem Cell Rev Rep 2023 Feb;19(2):550-567.
- Camargo Garbin L, McIlwraith CW, Frisbie DD. Evaluation of allogeneic freeze-dried platelet lysate in cartilage exposed to interleukin 1-β in vitro.. BMC Vet Res 2019 Nov 1;15(1):386.
- Chan CM, Macdonald CD, Litherland GJ, Wilkinson DJ, Skelton A, Europe-Finner GN, Rowan AD. Cytokine-induced MMP13 Expression in Human Chondrocytes Is Dependent on Activating Transcription Factor 3 (ATF3) Regulation.. J Biol Chem 2017 Feb 3;292(5):1625-1636.
- Kisiday JD, McIlwraith CW, Rodkey WG, Frisbie DD, Steadman JR. Effects of Platelet-Rich Plasma Composition on Anabolic and Catabolic Activities in Equine Cartilage and Meniscal Explants.. Cartilage 2012 Jul;3(3):245-54.
- Torzilli PA, Bhargava M, Chen CT. Mechanical Loading of Articular Cartilage Reduces IL-1-Induced Enzyme Expression.. Cartilage 2011 Oct 1;2(4):364-373.
- Wann AK, Mistry J, Blain EJ, Michael-Titus AT, Knight MM. Eicosapentaenoic acid and docosahexaenoic acid reduce interleukin-1β-mediated cartilage degradation.. Arthritis Res Ther 2010;12(6):R207.
- Malemud CJ. Anticytokine therapy for osteoarthritis: evidence to date.. Drugs Aging 2010 Feb 1;27(2):95-115.
- Torzilli PA, Bhargava M, Park S, Chen CT. Mechanical load inhibits IL-1 induced matrix degradation in articular cartilage.. Osteoarthritis Cartilage 2010 Jan;18(1):97-105.
- Macrory L, Vaughan-Thomas A, Clegg PD, Innes JF. An exploration of the ability of tepoxalin to ameliorate the degradation of articular cartilage in a canine in vitro model.. BMC Vet Res 2009 Jul 22;5:25.
- Wyatt KE, Bourne JW, Torzilli PA. Deformation-dependent enzyme mechanokinetic cleavage of type I collagen.. J Biomech Eng 2009 May;131(5):051004.
- Panico AM, Cardile V, Gentile B, Garufi F, Avondo S, Ronsisvalle S. "In vitro" differences among (R) and (S) enantiomers of profens in their activities related to articular pathophysiology.. Inflammation 2005 Dec;29(4-6):119-28.
- Embry Flory JJ, Fosang AJ, Knudson W. The accumulation of intracellular ITEGE and DIPEN neoepitopes in bovine articular chondrocytes is mediated by CD44 internalization of hyaluronan.. Arthritis Rheum 2006 Feb;54(2):443-54.
Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists